1262728

Richard Joseph Schmidt, MD, Inc. — FEI 3003971359

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
March 5, 2025
Fiscal Year
2025
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Mountain View, CA (United States)

Citations

IDCFRDescription
1221321 CFR 1271.47(a)Testing, screening, donor eligibility procedures
1224521 CFR 1271.55(d)(1)(ii)Results, interpretation of CD screening
1227221 CFR 1271.65(b)(2)Labeled re: biohazard, risks, test results
1227721 CFR 1271.75(a)(1)Risk factors, clinical evidence